NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

E2open, Sharecare And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Published 12/10/2023, 10:58
Updated 12/10/2023, 12:10
© Reuters.  E2open, Sharecare And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
BCS
-
PLNT
-
AKRO
-
DOYU
-
SHC
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stock futures traded higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.

  • Youdao, Inc. (NYSE: DAO) shares tumbled 8.1% to $4.00 in pre-market.
  • E2open Parent Holdings, Inc. (NYSE: ETWO) shares dipped 4.1% to $2.10 in pre-market trading as Redburn Atlantic analyst Alex Haissl downgraded the stock from Buy to Neutral and lowered the price target from $8.5 to $4. E2open shares fell 50% on Wednesday after the company reported second-quarter financial results.
  • FingerMotion, Inc. (NASDAQ: FNGR) shares declined 4.1% to $5.85 in pre-market trading after gaining 7% on Wednesday.
  • Planet Fitness, Inc. (NYSE: PLNT) shares fell 3.6% to $49.30 in pre-market trading after gaining around 3% on Wednesday.
  • Barclays PLC (NYSE: BCS) shares declined 3.5% to $7.55 in pre-market trading.
  • Sharecare, Inc. (NASDAQ: SHCR) shares tumbled 3.4% to $1.15 in pre-market trading after jumping 27% on Wednesday. On Oct. 3, director John Chadwick submitted a preliminary non-binding proposal to the board on behalf of private equity firm Claritas Capital, related to the proposed acquisition of all Sharecare shares not owned by reporting persons for $1.35 to $1.80 per share in cash.
  • Akero Therapeutics, Inc. (NASDAQ: AKRO) fell 3% to $14.60 in pre-market trading after declining 17% on Wednesday. Akero Therapeutics recently reported a 36-week analysis of SYMMETRY, a 96-week Phase 2b study of efruxifermin (EFX) in patients with compensated cirrhosis (F4) due to nonalcoholic steatohepatitis (NASH).

Now Read This: Investor Fears Ease Further Ahead Of More Inflation Data: Here's Why

Don’t forget to check out our premarket coverage here

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.